• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BCO
Click for more information
0.00% 12.5¢

BCD RESOURCES (OPERATIONS) NL - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
BCO +Annual Listing Fees - Removal from Official List30/08/11
BCORemoval from Official Listing of ASX26/08/11
BCOFinal Director's Interest Notice25/08/11
BCOBoard Changes25/08/11
AAS +Annual Listing Fees- Suspension from Official QuotationPRICE SENSITIVE23/08/11
BCOQuarterly Activities Report29/07/11
BCODetails of Registered office address01/07/11
BCOBoard Changes24/06/11
BCOQuarterly Activities Report29/04/11
BCOAppendix 3Z (x2)02/03/11
BCOAppendix 3Y (x2)02/03/11
BCOBoard and Management Changes02/03/11
BCOHalf Yearly Report and Accounts28/02/11
BCOQuarterly Activities Report31/01/11
BCOShare Trading Policy20/01/11
BCO2010 AGM Voting30/11/10
BCOResignation of Director23/11/10
BCONotice of 2010 AGM29/10/10
BCO2010 Annual Report29/10/10
BCOQuarterly Activities Report29/10/10
BCOFull Year Statutory Accounts30/09/10
BCOPreliminary Final Report31/08/10
BCOQuarterly Activities Report30/07/10
BCOQuarterly Activities Report30/04/10
BCOHalf Yearly Report and Accounts22/02/10
BCO +Annual Listing Fees - Removal from Official List
30/08/11
BCORemoval from Official Listing of ASX
26/08/11
BCOFinal Director's Interest Notice
25/08/11
BCOBoard Changes
25/08/11
AAS +Annual Listing Fees- Suspension from Official Quotation
23/08/11PRICE SENSITIVE
BCOQuarterly Activities Report
29/07/11
BCODetails of Registered office address
01/07/11
BCOBoard Changes
24/06/11
BCOQuarterly Activities Report
29/04/11
BCOAppendix 3Z (x2)
02/03/11
BCOAppendix 3Y (x2)
02/03/11
BCOBoard and Management Changes
02/03/11
BCOHalf Yearly Report and Accounts
28/02/11
BCOQuarterly Activities Report
31/01/11
BCOShare Trading Policy
20/01/11
BCO2010 AGM Voting
30/11/10
BCOResignation of Director
23/11/10
BCONotice of 2010 AGM
29/10/10
BCO2010 Annual Report
29/10/10
BCOQuarterly Activities Report
29/10/10
BCOFull Year Statutory Accounts
30/09/10
BCOPreliminary Final Report
31/08/10
BCOQuarterly Activities Report
30/07/10
BCOQuarterly Activities Report
30/04/10
BCOHalf Yearly Report and Accounts
22/02/10
refresh Created with Sketch. REFRESH
 

Top Stories

Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Panic, paranoia, and gangland politics: HotCopper users react to Dubber's missing $26M HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due to organised crime links.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.